We are live on
!
Find out more
CM
Crestline Management Portfolio holdings
AUM
$46.3M
1-Year Est. Return
48.82%
This Fund
S&P 500
This Quarter
Est. Return
+0.07%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$740M
AUM Growth
-$26.6M
(-3.5%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-1.57%
Top 10 Holdings %
Top 10 Hldgs %
45.11%
Holding
310
New
89
Increased
45
Reduced
51
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$16M |
| 2 |
MRSH
Marsh
MRSH
|
+$9.63M |
| 3 |
Goldman Sachs
GS
|
+$8.1M |
| 4 |
APi Group
APG
|
+$7.73M |
| 5 |
MBAC
M3-Brigade Acquisition II Corp.
MBAC
|
+$7.36M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$9.96M |
| 2 |
Denali Therapeutics
DNLI
|
+$9.75M |
| 3 |
Travelers Companies
TRV
|
+$9.3M |
| 4 |
Builders FirstSource
BLDR
|
+$8.41M |
| 5 |
Sonic Automotive
SAH
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.59% |
| 2 | Financials | 26.36% |
| 3 | Technology | 13.34% |
| 4 | Industrials | 9.39% |
| 5 | Materials | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Denali Therapeutics
DNLI
$3.65B
| $220M | 29.71% |
7,160,732
-300,000
| -4% | -$9.75M |
|
2
Sana Biotechnology
SANA
$871M
| $20.2M | 2.73% |
3,365,624
| – | – |
|
3
Zions Bancorporation
ZION
$10.2B
| $14.7M | 1.99% |
290,000
+40,000
| +16% | +$2.19M |
|
4
Allstate
ALL
$68B
| $14.3M | 1.94% |
115,000
+45,000
| +64% | +$5.59M |
|
|
5
US Bancorp
USB
$98.2B
| $13.9M | 1.88% |
+345,000
| New | +$16M |
|
|
AJRD
6
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $11.2M | 1.51% |
279,485
-58,120
| -17% | -$2.46M |
|
|
CMA
7
DELISTED
Comerica
CMA
| $10.7M | 1.44% |
150,000
+35,000
| +30% | +$2.76M |
|
8
Wells Fargo
WFC
$261B
| $10.4M | 1.41% |
259,337
+22,420
| +9% | +$963K |
|
9
NCR Voyix
VYX
$1.14B
| $9.59M | 1.3% |
822,268
+374,018
| +83% | +$6.86M |
|
|
MRSH
10
Marsh
MRSH
$90.5B
| $8.96M | 1.21% |
+60,000
| New | +$9.63M |
|
11
Mirion Technologies
MIR
$3.73B
| $8.39M | 1.13% |
1,123,857
-126,143
| -10% | -$888K |
|
12
Citizens Financial Group
CFG
$30.3B
| $8.25M | 1.11% |
240,000
+90,000
| +60% | +$3.33M |
|
13
Broadcom
AVGO
$1.85T
| $8.18M | 1.11% |
184,240
-19,140
| -9% | -$978K |
|
14
XPO
XPO
$23.6B
| $8.06M | 1.09% |
304,615
+46,081
| +18% | +$1.44M |
|
15
Aon
AON
$76.5B
| $8.04M | 1.09% |
30,000
-7,000
| -19% | -$1.98M |
|
|
MBAC
16
DELISTED
M3-Brigade Acquisition II Corp.
MBAC
| $7.36M | 0.99% |
+750,000
| New | +$7.36M |
|
|
17
Goldman Sachs
GS
$300B
| $7.33M | 0.99% |
+25,009
| New | +$8.1M |
|
18
Webster Financial
WBS
$12.5B
| $7.05M | 0.95% |
+156,000
| New | +$7.22M |
|
19
ESAB
ESAB
$5.38B
| $7.01M | 0.95% |
210,000
+60,000
| +40% | +$2.46M |
|
|
UNVR
20
DELISTED
Univar Solutions Inc.
UNVR
| $6.82M | 0.92% |
300,000
-32,000
| -10% | -$804K |
|
21
Royal Gold
RGLD
$16.8B
| $6.75M | 0.91% |
71,977
-5,400
| -7% | -$535K |
|
|
CLR
22
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $6.68M | 0.9% |
+100,000
| New | +$6.75M |
|
|
23
APi Group
APG
$17.2B
| $6.42M | 0.87% |
+725,717
| New | +$7.73M |
|
|
WCC
24
WESCO International
WCC
$16.7B
| $6.41M | 0.87% |
53,661
+3,661
| +7% | +$458K |
|
25
MetLife
MET
$61.9B
| $6.08M | 0.82% |
+100,000
| New | +$6.39M |
|
Similar funds
MCMC
RRC
PCM
NPCM
FCM
EGI
IPHI
SM
Crestline Management's Q3 2022 Portfolio in Review
As of Q3 2022, Crestline Management held 310 positions worth $740M, down 3.5% from $766M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Crestline Management's Q3 2022 filing shows 89 new, 45 increased, 51 reduced and 109 closed positions. Its largest new stake was US Bancorp: 345,000 shares worth $13.9M. The largest sale was Bank of America, an estimated $9.96M.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Financials and Technology.
- Crestline Management's largest Q3 2022 buy was US Bancorp: 345,000 shares worth $13.9M.
- Crestline Management added most to NCR Voyix in Q3 2022, an estimated $6.86M increase.
- Crestline Management's biggest Q3 2022 reduction was Denali Therapeutics, cutting an estimated $9.75M.
- Crestline Management fully exited Bank of America in Q3 2022, selling an estimated $9.96M.
- Crestline Management's ten largest holdings make up 45% of its $740M portfolio in Q3 2022.
- Crestline Management opened 89 new positions and closed 109 in Q3 2022.
- Crestline Management's portfolio value fell 3.5% quarter-over-quarter to $740M.
Based on Crestline Management's 13F filing for Q3 2022, filed 14 Nov 2022.